BioTech/Drugs - New York, New York, US
Eyenovia, Inc. (NASDAQ: EYEN), is an ophthalmic technology company developing the Optejet® device for use both in connection with its own drug-device therapeutic product candidates for presbyopia and pediatric progressive myopia as well as out-licensing for additional indications.
Outlook
Salesforce
Cloudflare DNS
Microsoft Office 365
CloudFlare Hosting